Evaluating Cost-effectiveness of Interventions That Affect Fertility and Childbearing: How Health Effects Are Measured Matters
- PMID: 25926281
- PMCID: PMC4418217
- DOI: 10.1177/0272989X15583845
Evaluating Cost-effectiveness of Interventions That Affect Fertility and Childbearing: How Health Effects Are Measured Matters
Abstract
Background: Current guidelines for economic evaluations of health interventions define relevant outcomes as those accruing to individuals receiving interventions. Little consensus exists on counting health impacts on current and future fertility and childbearing. Our objective was to characterize current practices for counting such health outcomes.
Methods: We developed a framework characterizing health interventions with direct and/or indirect effects on fertility and childbearing and how such outcomes are reported. We identified interventions spanning the framework and performed a targeted literature review for economic evaluations of these interventions. For each article, we characterized how the potential health outcomes from each intervention were considered, focusing on quality-adjusted life-years (QALYs) associated with fertility and childbearing.
Results: We reviewed 108 studies, identifying 7 themes: 1) Studies were heterogeneous in reporting outcomes. 2) Studies often selected outcomes for inclusion that tend to bias toward finding the intervention to be cost-effective. 3) Studies often avoided the challenges of assigning QALYs for pregnancy and fertility by instead considering cost per intermediate outcome. 4) Even for the same intervention, studies took heterogeneous approaches to outcome evaluation. 5) Studies used multiple, competing rationales for whether and how to include fertility-related QALYs and whose QALYs to include. 6) Studies examining interventions with indirect effects on fertility typically ignored such QALYs. 7) Even recent studies had these shortcomings. Limitations include that the review was targeted rather than systematic.
Conclusions: Economic evaluations inconsistently consider QALYs from current and future fertility and childbearing in ways that frequently appear biased toward the interventions considered. As the Panel on Cost-Effectiveness in Health and Medicine updates its guidelines, making the practice of cost-effectiveness analysis more consistent is a priority. Our study contributes to harmonizing methods in this respect.
Keywords: DALYs; QALYs; best practices; childbearing; cost-effectiveness analysis; economic evaluation; fertility; guidelines; pregnancy; quality of life.
© The Author(s) 2015.
Similar articles
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Cost-effectiveness of embryo transfer strategies: a decision analytic model using long-term costs and consequences of singletons and multiples born as a consequence of IVF.Hum Reprod. 2016 Nov;31(11):2527-2540. doi: 10.1093/humrep/dew229. Epub 2016 Oct 6. Hum Reprod. 2016. PMID: 27907897
-
Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.Pediatrics. 2005 May;115(5):e600-14. doi: 10.1542/peds.2004-2127. Pediatrics. 2005. PMID: 15867026 Review.
-
Systematic review of health economic studies in cranial neurosurgery.Neurosurg Focus. 2018 May;44(5):E2. doi: 10.3171/2018.2.FOCUS17792. Neurosurg Focus. 2018. PMID: 29712519
-
How are maternal and fetal outcomes incorporated when measuring benefits of interventions in pregnancy? Findings from a systematic review of cost-utility analyses.Health Qual Life Outcomes. 2024 Sep 11;22(1):75. doi: 10.1186/s12955-024-02293-4. Health Qual Life Outcomes. 2024. PMID: 39256866 Free PMC article.
Cited by
-
Sperm DNA Fragmentation: A New Guideline for Clinicians.World J Mens Health. 2020 Oct;38(4):412-471. doi: 10.5534/wjmh.200128. Epub 2020 Aug 6. World J Mens Health. 2020. PMID: 32777871 Free PMC article. Review.
-
Investigating the cost-effectiveness of three cessation interventions on a national scale using the Economics of Smoking in Pregnancy (ESIP) decision analytical model.Addiction. 2022 Nov;117(11):2907-2917. doi: 10.1111/add.15968. Epub 2022 Jun 14. Addiction. 2022. PMID: 35661312 Free PMC article.
-
Financing future fertility: Women's views on funding egg freezing.Reprod Biomed Soc Online. 2021 Aug 13;14:32-41. doi: 10.1016/j.rbms.2021.07.001. eCollection 2022 Mar. Reprod Biomed Soc Online. 2021. PMID: 34693043 Free PMC article.
-
Sperm DNA fragmentation testing in clinical management of reproductive medicine.Reprod Med Biol. 2023 Oct 31;22(1):e12547. doi: 10.1002/rmb2.12547. eCollection 2023 Jan-Dec. Reprod Med Biol. 2023. PMID: 37915974 Free PMC article. Review.
-
Sperm DNA fragmentation: a rationale for its clinical utility.Transl Androl Urol. 2017 Sep;6(Suppl 4):S455-S456. doi: 10.21037/tau.2017.03.63. Transl Androl Urol. 2017. PMID: 29082933 Free PMC article. No abstract available.
References
-
- National Institute for Health and Care Excellence (NICE) The Guidelines Manual. London, UK: NICE; 2012. - PubMed
-
- Gold MR, Siegel JE, Russell LB, Weinstein MC, editors. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996.
-
- Tan-Torres Edejer T, Baltussen R, Adam T, Hutubessy R, Acharya A, Evans DB, et al. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. Geneva, Switzerland: World Health Organization; 2003.
-
- Meltzer D. Accounting for future costs in medical cost-effectiveness analysis. J Health Econ. 1997 Feb;16(1):33–64. - PubMed
-
- Meltzer D, Johannesson M. Inconsistencies in the “societal perspective” on costs of the Panel on Cost-Effectiveness in Health and Medicine. Med Decis Making. 1999 Oct-Dec;19(4):371–7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials